Processa Pharmaceuticals ... (PCSA)
NASDAQ: PCSA
· Real-Time Price · USD
0.33
0.03 (9.78%)
At close: Jun 09, 2025, 3:59 PM
Processa Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.31 | -0.3 | -0.33 | -0.52 | -0.53 | -1.31 | -0.81 | -1.28 | 17.05 | -0.13 | -1.53 | -2.17 | -3.69 | -6.06 | -11.14 | -9.99 | -18.93 |
PEG Ratio | 0.00 | 0.02 | -0.17 | 0.06 | 0.03 | 0.10 | 0.04 | 0.00 | -0.17 | -0.00 | -0.1 | -0.04 | n/a | -1.15 | 2.23 | -0.23 | 0.24 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 439.89 | n/a | n/a | n/a |
PB Ratio | 1.00 | 1.93 | 1.21 | 1.04 | 0.65 | 2.53 | 0.94 | 1.46 | 1.12 | 2.42 | 2.12 | 2.23 | 2.05 | 3.03 | 4.89 | 4.32 | 5.07 |
P/FCF Ratio | n/a | -1.45 | -1.24 | -1.86 | -2.83 | -5.95 | -3.83 | -6.5 | -5.39 | -7.25 | -12.31 | -19.22 | -26.43 | -28.29 | -85.72 | -57.51 | -70.85 |
P/OCF Ratio | n/a | -1.45 | -1.25 | -1.86 | -2.83 | -5.95 | -3.83 | -6.5 | -5.39 | -7.25 | -12.31 | -19.22 | -26.43 | -28.29 | -85.72 | -57.51 | -70.85 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -15.55 | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.04 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Quick Ratio | 2.93 | 1.22 | 3.97 | 4.82 | 9.70 | 7.71 | 9.57 | 12.05 | 5.65 | 8.40 | 9.13 | 8.89 | 15.49 | 18.87 | 16.85 | 19.43 | 22.40 |
Current Ratio | 2.93 | 1.22 | 3.97 | 4.82 | 9.70 | 7.71 | 9.57 | 12.05 | 5.65 | 8.40 | 9.13 | 8.89 | 15.49 | 18.87 | 16.85 | 19.43 | 22.40 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -0.59 | n/a | n/a | n/a | 0.18 | -165.01 | n/a | -2.04K | -972.58 | -1.76K | -1.91K | -6.06K |
Return on Equity | -0.8 | -1.61 | -0.91 | -0.5 | -0.31 | -0.48 | -0.29 | -0.29 | 0.02 | -4.61 | -0.35 | -0.26 | -0.14 | -0.12 | -0.11 | -0.11 | -0.07 |
Return on Assets | -0.59 | -0.84 | -0.68 | -0.4 | -0.27 | -0.42 | -0.26 | -0.26 | 0.01 | -3.99 | -0.32 | -0.24 | -0.13 | -0.12 | -0.1 | -0.1 | -0.06 |
Return on Invested Capital | n/a | -1.61 | -0.9 | -0.49 | -0.62 | -0.87 | -0.6 | -0.29 | 0.02 | 0.50 | -0.34 | -0.26 | -0.14 | -0.12 | -0.11 | -0.11 | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.25 | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.15 | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.19 | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19.21 | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.06 | n/a | n/a | n/a |